These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 22040203)

  • 1. Can ovarian reserve assessment predict fertility following breast cancer treatment?
    Anderson RA
    Womens Health (Lond); 2011 Nov; 7(6):623-5. PubMed ID: 22040203
    [No Abstract]   [Full Text] [Related]  

  • 2. Breast cancer and fertility preservation.
    Schattman GL; Navarro J
    Placenta; 2008 Oct; 29 Suppl B():147-51. PubMed ID: 18790327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gonadotropin-Releasing Hormone Agonists for Ovarian Function Preservation in Premenopausal Women Undergoing Chemotherapy for Early-Stage Breast Cancer: A Systematic Review and Meta-analysis.
    Munhoz RR; Pereira AA; Sasse AD; Hoff PM; Traina TA; Hudis CA; Marques RJ
    JAMA Oncol; 2016 Jan; 2(1):65-73. PubMed ID: 26426573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fertility conservation in breast cancer patients.
    Lawrenz B; Henes M; Neunhoeffer E; Kraemer B; Fehm T
    Womens Health (Lond); 2011 Mar; 7(2):203-12. PubMed ID: 21410346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fertility preservation for breast cancer patients.
    Oktem O; Oktay K
    Semin Reprod Med; 2009 Nov; 27(6):486-92. PubMed ID: 19806518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Breast cancer and fertility: critical review, considerations and perspectives].
    This P
    Bull Cancer; 2008 Jan; 95(1):17-25. PubMed ID: 18230566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Failure of Ovarian Suppression With Gonadotropin-Releasing Hormone Analogs to Preserve Fertility: An Assessment Based on the Quality of Evidence.
    Oktay K; Turan V
    JAMA Oncol; 2016 Jan; 2(1):74-5. PubMed ID: 26426406
    [No Abstract]   [Full Text] [Related]  

  • 8. Impact of breast cancer chemotherapy on ovarian reserve: a prospective observational analysis by menstrual history and ovarian reserve markers.
    Reh A; Oktem O; Oktay K
    Fertil Steril; 2008 Nov; 90(5):1635-9. PubMed ID: 18166178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fertility after breast cancer treatment.
    Kasum M; Beketić-Orešković L; Peddi PF; Orešković S; Johnson RH
    Eur J Obstet Gynecol Reprod Biol; 2014 Feb; 173():13-8. PubMed ID: 24315568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Adjuvant chemotherapy for breast cancer and fertility: estimation of the impact, options of preservation and role of the oncologist].
    Mailliez A; Decanter C; Bonneterre J
    Bull Cancer; 2011 Jul; 98(7):741-51. PubMed ID: 21700552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fertility preservation options for young women with breast cancer.
    Hulvat MC; Jeruss JS
    Curr Opin Obstet Gynecol; 2011 Jun; 23(3):174-82. PubMed ID: 21415746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fertility preservation in women with breast cancer undergoing adjuvant chemotherapy: a systematic review.
    Cruz MR; Prestes JC; Gimenes DL; Fanelli MF
    Fertil Steril; 2010 Jun; 94(1):138-43. PubMed ID: 19339000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemotherapy and fertility.
    Blumenfeld Z
    Best Pract Res Clin Obstet Gynaecol; 2012 Jun; 26(3):379-90. PubMed ID: 22281514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of chemotherapy-induced ovarian damage in breast cancer patients.
    Codacci-Pisanelli G; Del Pup L; Del Grande M; Peccatori FA
    Crit Rev Oncol Hematol; 2017 May; 113():90-96. PubMed ID: 28427528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controversies in preservation of ovary function and fertility in patients with breast cancer.
    Gerber B; Dieterich M; Müller H; Reimer T
    Breast Cancer Res Treat; 2008 Mar; 108(1):1-7. PubMed ID: 17457668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preventing ovarian failure associated with chemotherapy.
    Cui W; Stern C; Hickey M; Goldblatt F; Anazodo A; Stevenson WS; Phillips KA
    Med J Aust; 2018 Nov; 209(9):412-416. PubMed ID: 30376664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of chemotherapy-induced ovarian damage.
    Roness H; Kashi O; Meirow D
    Fertil Steril; 2016 Jan; 105(1):20-9. PubMed ID: 26677788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GnRH analogue for chemotherapy-induced ovarian damage: too early to say?
    Peccatori F; Demeestere I
    Fertil Steril; 2009 Aug; 92(2):e33; author reply e34. PubMed ID: 19646600
    [No Abstract]   [Full Text] [Related]  

  • 19. Cancer and fertility preservation: fertility preservation in breast cancer patients.
    Maltaris T; Weigel M; Mueller A; Schmidt M; Seufert R; Fischl F; Koelbl H; Dittrich R
    Breast Cancer Res; 2008; 10(2):206. PubMed ID: 18492214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel hGHRH homodimer promotes fertility of female infertile hamster by up-regulating ovarian GHRH receptor without triggering GH secretion.
    Zhang JH; Zhang XD; Yue LN; Guo XY; Tang JX; Guo LR; Li Y; Tang SS
    Eur J Pharm Sci; 2018 May; 117():341-350. PubMed ID: 29526766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.